Changes in Structure and Symptoms in Knee Osteoarthritis and Prediction of Future Knee Replacement Over 8 Years

How to define responders in osteoarthritis

(2013) Cyrus Cooper et al.   CURRENT MEDICAL RESEARCH AND OPINION

Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation

(2011) J.-P. Raynauld et al.   ANNALS OF THE RHEUMATIC DISEASES

OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group

(2011) L. GOSSEC et al.   JOURNAL OF RHEUMATOLOGY

OARSI–OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials

(2011) R.L. Manno et al.   OSTEOARTHRITIS AND CARTILAGE

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement

(2010) L. Gossec et al.   OSTEOARTHRITIS AND CARTILAGE

Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement: a longitudinal study

(2010) S. K. Tanamas et al.   RHEUMATOLOGY

OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs

(2009) M. DOUGADOS et al.   JOURNAL OF RHEUMATOLOGY

OARSI–OMERACT definition of relevant radiological progression in hip/knee osteoarthritis

(2009) P. Ornetti et al.   OSTEOARTHRITIS AND CARTILAGE

Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials

(2007) O. Bruyere et al.   OSTEOARTHRITIS AND CARTILAGE